Literature DB >> 11534670

The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours--a prospective study.

F W Kreth1, A Muacevic, R Medele, K Bise, T Meyer, H J Reulen.   

Abstract

OBJECTIVE: To analyze prospectively the frequency and the risk of symptomatic and asymptomatic haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours.
METHODS: The study was conducted within a time frame of 24 months (April 1998-April 2000). 326 patients (150 males, 176 females; mean age 56.8 years) were included and 345 computerized tomography (CT)-guided stereotactic biopsies were performed/supervised by a specialized stereotactic neurosurgeon. A modified Riechert Stereotaxy System and a workstation for multiplanar trajectory planning were used in all patients. Serial biopsies (median, 5 samples) were done with small forceps (diameter 1 mm), smear preparations of the biopsy specimens were intra-operatively examined. Frequency, size, and location of any detectable bleeding were analyzed by post-biopsy CT-scan investigation. For risk estimation, logistic regression analysis was performed. The chi-square statistic was used for comparative analysis of the study results with available data from the literature.
RESULTS: A conclusive tissue diagnosis could be achieved in 98%. Overall treatment morbidity was 3.1%. There was no mortality. Haemorrhage related morbidity was 0.9%. Age, Karnofsky score, mass effect of the tumour, tumour histology, tumour location and the number of specimens taken did not have any prognostic significance. The clinically silent bleeding rate was 9.6% and more often seen in patients with high grade gliomas (p = 0.03). Both the silent and non-silent bleeding rate were significantly lower as compared to available prospective data in the literature (p < 0.01).
CONCLUSION: Using multiplanar image guided trajectory planning, small biopsy forceps and intra-operative smear preparations the risk of major haemorrhage related morbidity after stereotactic brain tumour biopsy is extremely low (<1%) in experienced hands.

Entities:  

Mesh:

Year:  2001        PMID: 11534670     DOI: 10.1007/s007010170058

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  42 in total

1.  Interstitial iodine-125 radiosurgery alone or in combination with microsurgery for pediatric patients with eloquently located low-grade glioma: a pilot study.

Authors:  A Peraud; C Goetz; A Siefert; J C Tonn; F W Kreth
Journal:  Childs Nerv Syst       Date:  2006-09-14       Impact factor: 1.475

2.  Stereotactic biopsy in elderly patients: risk assessment and impact on treatment decision.

Authors:  Stephanie G Kellermann; Christina A Hamisch; Daniel Rueß; Tobias Blau; Roland Goldbrunner; Harald Treuer; Stefan J Grau; Maximilian I Ruge
Journal:  J Neurooncol       Date:  2017-06-21       Impact factor: 4.130

3.  Radiation dose and image quality in intraoperative CT (iCT) angiography of the brain with stereotactic head frames.

Authors:  Robert Forbrig; Lucas L Geyer; Robert Stahl; Jun Thorsteinsdottir; Christian Schichor; Friedrich-Wilhelm Kreth; Maximilian Patzig; Moriz Herzberg; Thomas Liebig; Franziska Dorn; Christoph G Trumm
Journal:  Eur Radiol       Date:  2019-01-11       Impact factor: 5.315

4.  Treatment of glioblastoma in elderly patients.

Authors:  Florian Stockhammer
Journal:  CNS Oncol       Date:  2014-03

5.  Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.

Authors:  Garry Ceccon; Philipp Lohmann; Gabriele Stoffels; Natalie Judov; Christian P Filss; Marion Rapp; Elena Bauer; Christina Hamisch; Maximilian I Ruge; Martin Kocher; Klaus Kuchelmeister; Bernd Sellhaus; Michael Sabel; Gereon R Fink; Nadim J Shah; Karl-Josef Langen; Norbert Galldiks
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300

6.  Use of intra-operative stimulation of brainstem lesion target sites for frameless stereotactic biopsies.

Authors:  Jason Labuschagne; Denis Mutyaba; Jacques Nel; Claudia Casieri
Journal:  Childs Nerv Syst       Date:  2021-03-08       Impact factor: 1.475

7.  FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

Authors:  Gabriele Pöpperl; Friedrich W Kreth; Jan H Mehrkens; Jochen Herms; Klaus Seelos; Walter Koch; Franz J Gildehaus; Hans A Kretzschmar; Jörg C Tonn; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-01       Impact factor: 9.236

8.  Surgical resection plus stereotactic 125I brachytherapy in adult patients with eloquently located supratentorial WHO grade II glioma - feasibility and outcome of a combined local treatment concept.

Authors:  O Schnell; K Schöller; M Ruge; A Siefert; J-C Tonn; F W Kreth
Journal:  J Neurol       Date:  2008-07-25       Impact factor: 4.849

9.  Tubular brain tumor biopsy improves diagnostic yield for subcortical lesions.

Authors:  Evan D Bander; Samuel H Jones; David Pisapia; Rajiv Magge; Howard Fine; Theodore H Schwartz; Rohan Ramakrishna
Journal:  J Neurooncol       Date:  2018-11-16       Impact factor: 4.130

10.  The positive predictive value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment.

Authors:  J H Mehrkens; G Pöpperl; W Rachinger; J Herms; K Seelos; K Tatsch; J C Tonn; F W Kreth
Journal:  J Neurooncol       Date:  2008-01-23       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.